We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$60.5B
AUM Growth
+$8.17B
(+16%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
5.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
3,520
New
510
Increased
1,636
Reduced
1,103
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$141M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$128M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$125M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$117M |
| 5 |
Apple
AAPL
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$131M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$77.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$62.1M |
| 4 |
UnitedHealth
UNH
|
+$35.8M |
| 5 |
CBRE Group
CBRE
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Financials | 6.58% |
| 3 | Industrials | 4.51% |
| 4 | Consumer Discretionary | 3.84% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Leslie's
LESL
$11M
| $36.8K | ﹤0.01% |
4,405
+2,541
| +136% | +$33.5K |
|
|
MRSN
3252
DELISTED
Mersana Therapeutics
MRSN
| $36.7K | ﹤0.01% |
5,069
-159
| -3% | -$1.4K |
|
3253
CALL
Grab
GRAB
$14.9B
| $36K | ﹤0.01% |
25,000
+14,500
| +138% | +$67.6K |
|
3254
PUT
ExxonMobil
XOM
$634B
| $36K | ﹤0.01% |
16,500
-10,700
| -39% | -$1.14M |
|
3255
Banco Bradesco
BBD
$36.7B
| $34.3K | ﹤0.01% |
11,049
-31,339
| -74% | -$82.4K |
|
3256
Clear Channel Outdoor Holdings
CCO
$1.23B
| $34.2K | ﹤0.01% |
27,591
+5,145
| +23% | +$5.56K |
|
3257
Mammoth Energy Services
TUSK
$163M
| $33.9K | ﹤0.01% |
+12,121
| New | +$31K |
|
3258
Solitario Resources
XPL
$72.9M
| $33.3K | ﹤0.01% |
52,000
| – | – |
|
3259
Rafael Holdings
RFL
$107M
| $32.5K | ﹤0.01% |
17,203
+3,316
| +24% | +$5.4K |
|
3260
Ampco-Pittsburgh
AP
$193M
| $32.3K | ﹤0.01% |
+11,154
| New | +$28.9K |
|
3261
ADC Therapeutics
ADCT
$144M
| $32K | ﹤0.01% |
11,232
-3,758
| -25% | -$7.91K |
|
3262
Tilray
TLRY
$622M
| $31.6K | ﹤0.01% |
5,857
-1,154
| -16% | -$5.24K |
|
3263
SES AI
SES
$208M
| $31.3K | ﹤0.01% |
35,450
+3,129
| +10% | +$2.63K |
|
3264
Erasca
ERAS
$6.39B
| $30.7K | ﹤0.01% |
21,349
-6,790
| -24% | -$9.09K |
|
|
MIN
3265
Aberdeen Intermediate Income Fund
MIN
$278M
| $30.4K | ﹤0.01% |
11,283
+1,048
| +10% | +$2.8K |
|
3266
Caribou Biosciences
CRBU
$164M
| $30.3K | ﹤0.01% |
22,083
+4,132
| +23% | +$4.06K |
|
|
FAZ
3267
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
| $30K | ﹤0.01% |
+4,000
| New | +$214K |
|
3268
Black Diamond Therapeutics
BDTX
$112M
| $28.3K | ﹤0.01% |
+10,984
| New | +$21.2K |
|
|
OKYO
3269
OKYO Pharma
OKYO
$78.2M
| $27.8K | ﹤0.01% |
+10,000
| New | +$16.9K |
|
3270
Coherus Oncology
CHRS
$196M
| $27.8K | ﹤0.01% |
34,275
+1,026
| +3% | +$886 |
|
3271
Lexaria Bioscience
LEXX
$8.71M
| $27.7K | ﹤0.01% |
2,052
-12
| -0.6% | -$207 |
|
3272
Standard BioTools
LAB
$314M
| $27.5K | ﹤0.01% |
20,356
+106
| +0.5% | +$118 |
|
3273
MAIA Biotechnology
MAIA
$86.3M
| $27.4K | ﹤0.01% |
14,800
| – | – |
|
|
NB
3274
NioCorp Developments
NB
$780M
| $27.2K | ﹤0.01% |
+11,305
| New | +$28.2K |
|
3275
Ring Energy
REI
$339M
| $26.7K | ﹤0.01% |
33,729
-48,830
| -59% | -$41.3K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q2 2025 Portfolio in Review
As of Q2 2025, Wealth Enhancement Advisory Services held 3,520 positions worth $60.5B, up 16% from $52.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wealth Enhancement Advisory Services deployed $3.47B of net new capital in Q2 2025, opening 510 new positions and adding to 1,636 existing holdings. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Palantir, an estimated $131M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
- Wealth Enhancement Advisory Services added most to iShares Core US Aggregate Bond ETF in Q2 2025, an estimated $128M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2025 reduction was Palantir, cutting an estimated $131M.
- Wealth Enhancement Advisory Services fully exited Discover Financial Services in Q2 2025, selling an estimated $10.8M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 24% of its $60.5B portfolio in Q2 2025.
- Wealth Enhancement Advisory Services opened 510 new positions and closed 162 in Q2 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 16% quarter-over-quarter to $60.5B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.